Open-label Extension (OLE) Study of WVE-004 in Patients With C9orf72-associated Amyotrophic Lateral Sclerosis (ALS) and/or Frontotemporal Dementia (FTD)
Clinical trial NCT05683860 · TERMINATED
Trial details
- NCT number
- NCT05683860
- Sponsor
- Wave Life Sciences USA, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-14
- Primary completion
- 2023-06-30
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.